An intelligent decision support algorithm for diagnosis of colorectal cancer through serum tumor markers

Computer Methods and Programs in Biomedicine

Volumn 100, Issue 2, 2010, Pages 97-107

  Shi, Jinghua ^a   Su, Qiang ^d   Zhang, Chenpeng ^b   Huang, Gang ^b   Zhu, Yan ^c  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c Tsinghua University   (China)

^d TONGJI UNIVERSITY   (China)

Author keywords

Colorectal cancer; Cutoff points; Diagnostic accuracy; Serum tumor markers

Indexed keywords

ARTIFICIAL INTELLIGENT; COLORECTAL CANCER; CUTOFF POINTS; DATA SETS; DECISION SUPPORTS; DIAGNOSTIC ACCURACY; EXPERIMENTAL STUDIES; INTELLIGENT DECISION SUPPORT; SERIAL TEST; SERUM TUMOR MARKERS; TUMOR MARKERS;

ARTIFICIAL INTELLIGENCE; BODY FLUIDS; COST REDUCTION; DECISION SUPPORT SYSTEMS; STATISTICAL TESTS;

TUMORS;

TUMOR MARKER;

ALGORITHM; ARTICLE; CLINICAL DECISION MAKING; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HUMAN; MAJOR CLINICAL STUDY; PHYSICIAN; VALIDATION STUDY;

ALGORITHMS; COLORECTAL NEOPLASMS; DECISION SUPPORT SYSTEMS, CLINICAL; HUMANS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 77956651863     PISSN: 01692607     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cmpb.2010.03.001     Document Type: Article

References (34)

1. Plebani M., de Paoli M., Basso D., Roveroni G., Giacomini A., Galeotti F., Corsini A. Serum tumor markers in colorectal cancer staging, grading, and follow-up. Journal of Surgical Oncology 1996, 62(4):239-244.
2. Carpelan-Holmstrom M., Louhimo J., Stenman U.-H., Alfthan H., Jarvinen H., Haglund C. Estimating the probability of cancer with several tumor markers in patients with colorectal disease. Oncology 2004, 66(4):296-302.
3. Nilsson O., Johansson C., Glimelius B., Persson B., Norgaard-Pedersen B., Andren-Sanberg A., Lindholm L. Sensitivity and specificity of CA242 in gastro-intestinal cancer. A comparison with CEA, CA50 and CA 19-9. British Journal of Cancer 1992, 65(2):215-221.
4. Filella X., Molina R., Grau J.J., Pique J.M., Garcia-Valdecasas J.C., Astudilo E., Biete A., Bordas J.M., Novell A., Campo E., Ballesta A.M. Prognostic value of CA19.9 levels in colorectal cancer. Annals of Surgery 1992, 216(1):55-59.
5. Guadagni F., Roselli M., Cosimelli M., Mannella E., Tedesco M., Cavaliere F., Grassi A., Abbolito M.R., Greiner J.W., Schlom J. TAG-72 (CA72-4 assay) as a complementary serum tumor antigen to carcinoembryonic antigen in monitoring patients with colorectal cancer. Cancer 1993, 72(7):2098-2106.
6. Gion M., Barioli P., Ponti A., Torri V., Mione R., Dittadi R. How tumor markers are used in the routine follow-up of breast and colorectal cancer. A survey of 29 Italian hospitals. International Journal of Biological Marker 1998, 13(3):124-138.
7. Korner H., Soreide K., Stokkeland P.J., Soreide J.A. Diagnostic accuracy of serum-carcinoembryonic antigen in recurrent colorectal cancer: a receiver operating characteristic curve analysis. Annals of Surgical Oncology 2007, 14:417-423.
8. Armitage N.C., Davidson A., Tsikos D., Wood C.B. A study of reliability of carcinoembryonic antigen blood levels in following the course of colorectal cancer. Clinical Oncology 1984, 10:141-147.
9. Wichmann M.W., Lau-Werner U., Muller C., Hornung H.M., Stieber P., Schildberg F.W. Carcinoembryonic antigen for the detection of recurrent disease following curative resection of colorectal cancer. Anticancer Research 2000, 20:4953-4955.
10. Carriquiry L.A., Piñeyro A. Should carcinoembryonic antigen be used in the management of patients with colorectal cancer?. Diseases of the Colon and Rectum 1999, 42:921-929.
11. Weiss H.L., Niwas S., Grizzle W.E., Piyathilake C. Receiver operating characteristic (ROC) to determine cut-off points of biomarkers in lung cancer patients. Disease Markers 2003, 19:273-278.
12. Wan S., Zhang B. Smooth semiparametric receiver operating characteristic curves for continuous diagnostic tests. Statistics in Medicine 2007, 26(12):2565-2586.
13. Carpelan-Holmstrom M., Haglund C., Kuusela P., Jarvinen H., Roberts P.J. Preoperative serum levels of CEA and CA 242 in colorectal cancer. British Journal of Cancer 1995, 71:868-872.
14. Wood C.B., Ratcliffe J.G., Burt R.W., Malcolm A.J., Blumgart L.H. The clinical significance of the pattern of elevated serum carcinoembryonic antigen (CEA) levels in recurrent colorectal cancer. British Journal of Surgery 1980, 67:46-48.
15. Persijn J.P., Hart A.A. Prognostic significance of CEA in colorectal cancer: a statistical study. Journal of Clinical Chemistry and Clinical Biochemistry 1981, 19(11):1117-1123.
16. Duffy M.J. Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful?. Clinical Chemistry 2001, 47:624-630.
17. Moertel C.G., Fleming T.R., Macdonald J.S., Haller D.G., Laurie J.A., Tangen C. An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. Journal of the American Medical Association 1993, 270:943-947.
18. Yu C., Xu Y. Basic principals of ROC analysis. Chinese Journal of Epidemiology 1998, 9:413-415.
19. Streiner D.L., Cairney J. What's under the ROC? An introduction to receiver operating characteristics curves. Canadian Journal of Psychiatry 2007, 52:121-128.
20. Fayyad U., Irani K. On the handling of continuous-valued attributes in decision tree generation. Machine Learning 1992, 8(1):87-102.
21. Liu H., Hussain F., Tan C.L., Dash M. Discretization: an enabling technique. Data Mining and Knowledge Discovery 2002, 6(4):393-423.
22. de R.L., Mantaras A distance-based attribute selection measure for decision tree induction. Machine Learning 1991, 6(1):81-92.
23. Su Q., Shi J.-H., Lai S.-J. Study on supply chain management of Chinese firms from the institutional view. International Journal of Production Economics 2008, 115(2):362-373.
24. Park Y.-J., Kim B.-C., Chun S.-H. New knowledge extraction technique using probability for case-based reasoning: application to medical diagnosis. Expert Systems 2006, 23(1):2-20.
25. Ahn H., Kim K.-J. Global optimization of case-based reasoning for breast cytology diagnosis. Expert Systems with Applications 2009, 36(1):724-734.
26. Li H., Sun J., Sun B.-L. Financial distress prediction based on OR-CBR in the principle of k-nearest neighbors. Expert Systems with Application 2009, 36(1):643-659.
27. Lopez B., Gay P., Pla A., Pous C. A framework for CBR development and experimentation with application to medical diagnosis. Advances in Soft Computing 2009, 49:45-54.
28. Ong L.S., Shepherd B., Tong L.C., Seow-Chown F., Ho Y.H., Tang C.L., Ho Y.S., Tan K. The colorectal cancer recurrence support (CARES) system. Artificial Intelligence in Medicine 1997, 11(3):175-188.
29. Su Q. Applying case-based reasoning in assembly sequence planning. International Journal of Production Research 2007, 45(1):29-47.
30. Thangavel K., Pethalakshmi A. Dimensionality reduction based on rough set theory: a review. Applied Soft Computing 2009, 9(1):1-12.
31. Wang X.Y., Yang J., Jensen R., Liu X.J. Rough set feature selection and rule induction for prediction of malignancy degree in brain glioma. Computer Methods and Programs in Biomedicine 2006, 83(2):147-156.
32. Odajima K., Hayashi Y., Tianxia G., Setiono R. Greedy rule generation from discrete data and its use in neural network rule extraction. Neural Networks 2008, 21(7):1020-1028.
33. Appavu S., Rajaram R. Knowledge-based system for text classification using ID6NB algorithm. Knowledge-Based Systems 2009, 22(1):1-7.
34. Lewandowski M., Szwed H., Kowalik I. Searching for the optimal strategy for the diagnosis of stable coronary artery disease: cost effectiveness of the new algorithm. Cardiology Journal 2007, 14(6):544-551.